Literature DB >> 17322470

Positive correlation between vitreous levels of advanced glycation end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently treated with photocoagulation.

Masahiko Yokoi, Sho-ichi Yamagishi, Masayoshi Takeuchi, Takanori Matsui, Yumiko Yoshida, Kazuhiro Ohgami, Tamami Amano-Okamoto, Shigeaki Ohno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17322470      PMCID： PMC1857672          DOI： 10.1136/bjo.2006.100198

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  Y Mitamura; S Takeuchi; A Matsuda; Y Tagawa; Y Mizue; J Nishihira
Journal:  Ophthalmologica       Date:  2001 Nov-Dec       Impact factor: 3.250

2.  Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.

Authors:  M Yokoi; S-I Yamagishi; M Takeuchi; K Ohgami; T Okamoto; W Saito; M Muramatsu; T Imaizumi; S Ohno
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

3.  Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes.

Authors:  Sho-ichi Yamagishi; Shinjiro Amano; Yosuke Inagaki; Tamami Okamoto; Kohachiro Koga; Nobuyuki Sasaki; Hiroshi Yamamoto; Masayoshi Takeuchi; Zenji Makita
Journal:  Biochem Biophys Res Commun       Date:  2002-01-25       Impact factor: 3.575

Review 4.  Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Authors:  Sho-ichi Yamagishi; Tsutomu Imaizumi
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

5.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.

Authors:  M J Tolentino; J W Miller; E S Gragoudas; F A Jakobiec; E Flynn; K Chatzistefanou; N Ferrara; A P Adamis
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

6.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
  6 in total
  4 in total

Review 1.  [Diabetic maculopathy. Diagnosis and treatment].

Authors:  F Gelisken; F Ziemssen
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

2.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

3.  Advanced glycation end product (AGE) modified proteins in tears of diabetic patients.

Authors:  Zhenjun Zhao; Jingfang Liu; Bingyin Shi; Shuixiang He; Xiaoli Yao; Mark D P Willcox
Journal:  Mol Vis       Date:  2010-08-11       Impact factor: 2.367

Review 4.  Effects of Toxic AGEs (TAGE) on Human Health.

Authors:  Masayoshi Takeuchi; Akiko Sakasai-Sakai; Takanobu Takata; Jun-Ichi Takino; Yoshiki Koriyama
Journal:  Cells       Date:  2022-07-12       Impact factor: 7.666
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.